Landaas & CO Bristol Myers Squibb CO Transaction History

Landaas & CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $130,965 - $147,719	-2,373 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$50.53 - $62.98 $119,907 - $149,451	2,373 New	2,373 $131,000
Q1 2018 May 14, 2018	SELL	$59.92 - $68.98 $141,950 - $163,413	-2,369 Closed	0 $0
Q4 2017 Feb 06, 2018	BUY	$59.94 - $65.35 $119 - $130	2 Added 0.08%	2,369 $145,000
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $130,729 - $150,872	2,367	2,367 $151,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Landaas & CO , based on Form 13F filings with the SEC.

Stay updated on Landaas & CO with notifications on news.